-transparent.png){kind=logo}
We examined how a combination of pharmacologic agents ("rescue" agents) affect the function of hypothermically preserved dog kidneys at the time of reperfusion. Dog kidneys were preserved either by simple cold storage in EuroCollins' solution for 24 or 48 hours or by continuous perfusion at 5 degrees C in Belzer's gluconate-hydroxyethyl starch solution for as long as 5 days. After preservation, renal functions were measured with the isolated perfused kidney model. Kidneys were reperfused at normothermia either with or without the addition of a combination of rescue agents to the reperfusion medium. The rescue agents studied were allopurinol (1 mmol/L); superoxide dismutase (32,000 U/L); catalase (137,500 U/L); dimethylthiourea (3 mmol/L); glutathione (3 mmol/L); desferrioxamine (0.2 gm/L), for protection against O2 free radical injury and lipid peroxidation injury; verapamil (25 mg/L), as a Ca channel blocker; and ATP-MgCl2 (0.3 mmol/L), to stimulate energy metabolism. The renal functions we measured were glomerular filtration rate (GFR) (creatinine clearance), urine production, perfusate flow, urinary protein concentration, Na reabsorptive capacity, and tissue concentrations of ATP, K, and total tissue water. GFR was reduced by 75% to 90% after all periods of preservation, and the rescue agents had no effect on GFR. Sodium reabsorption was reduced from 98% to a range of 40% to 50% after 48 hours of cold storage or 5 days of machine perfusion and was not increased by rescue agents. There was a time-dependent increase in the amount of urine protein that was not affected by rescue agents. The addition of rescue agents did not affect total tissue water or concentrations of ATP or K in kidneys after normothermic reperfusion. These results demonstrate that pharmacologic agents previously suggested to suppress reperfusion damage in kidneys are not effective in this model. Therefore it is likely that kidneys damage occurs primarily during preservation, which suggest that optimal function on reperfusion calls for the development of better methods of preservation.
R J Ploeg, and
P Vreugdenhil, and
D Goossens, and
J F McAnulty, and
J H Southard, and
F O Belzer
February 1989,
Transplantation proceedings,
R J Ploeg, and
P Vreugdenhil, and
D Goossens, and
J F McAnulty, and
J H Southard, and
F O Belzer
November 1978,
Transplantation,
R J Ploeg, and
P Vreugdenhil, and
D Goossens, and
J F McAnulty, and
J H Southard, and
F O Belzer
January 1980,
Bratislavske lekarske listy,
R J Ploeg, and
P Vreugdenhil, and
D Goossens, and
J F McAnulty, and
J H Southard, and
F O Belzer
March 2004,
World journal of gastroenterology,
R J Ploeg, and
P Vreugdenhil, and
D Goossens, and
J F McAnulty, and
J H Southard, and
F O Belzer
July 1980,
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
R J Ploeg, and
P Vreugdenhil, and
D Goossens, and
J F McAnulty, and
J H Southard, and
F O Belzer
December 1973,
The American journal of cardiology,
R J Ploeg, and
P Vreugdenhil, and
D Goossens, and
J F McAnulty, and
J H Southard, and
F O Belzer
June 2014,
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie,
R J Ploeg, and
P Vreugdenhil, and
D Goossens, and
J F McAnulty, and
J H Southard, and
F O Belzer
April 1992,
Molecular and cellular biochemistry,
R J Ploeg, and
P Vreugdenhil, and
D Goossens, and
J F McAnulty, and
J H Southard, and
F O Belzer
December 1959,
Surgery, gynecology & obstetrics,
R J Ploeg, and
P Vreugdenhil, and
D Goossens, and
J F McAnulty, and
J H Southard, and
F O Belzer
January 1977,
European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
